In ter leukin-1β-converting Enzyme Mediates Cisplatin-induced Apoptosis in Malignant Glioma Cells

Cancer Research

Volumn 55, Issue 24, 1995, Pages 6166-6171

  Kondo, Seiji ^a   Barna, Barbara P ^a   Morimura, Tatsuo ^b   Takeuchi, Juji ^b   Yuan, Junying ^c   Akbasak, Aytac ^d   Barnett, Gene H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UTANO NATIONAL HOSPITAL   (Japan)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; INTERLEUKIN 1BETA;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN TUMOR; CANCER SUSCEPTIBILITY; CELL DEATH; ENZYME INHIBITION; GENE EXPRESSION; GENE INDUCTION; GLIOMA CELL; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; ANIMAL; APOPTOSIS; CASPASE 1; CISPLATIN; CYCLINS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMAN; INTERLEUKIN-1; MICE; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PROTEIN P53; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0028885644     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Schoenberg, B. S. In:M. D. Walker (ed.), Oncology of the Nervous System, pp. 1–30. Boston:Nijhoff, 1983.
2. Deen, F. D., Chiarado, A., Grimm, E. A., Fike, J. R., Israel, M. A., Kun, L. E., Levin, V. A., Marton, L. J., Packer, R. J., Pegg, A. E., Rosenblum, M. L., Suit, H. D., Walker, M. D., Wikstrand, C. J., Wilson, C. B., Wong, A. J., and Yung, W. K. A. Brain tumor working group report on the 9th International Conference on Brain Tumor Research and Therapy. J. Neuro-Oncol., 16:243–272, 1993.
3. Weiler, M., Frei, K., Groscurth, P., Krammer, P. H., Yonekawa, Y., and Fontana, A. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells, induction and modulation of sensitivity by cytokines. J. Clin. Invest., 94:954–964, 1994.
4. Korsmeyer, S. J. Bcl-2:an antidote to programmed cell death. Cancer Surv., 75:105–118, 1992.
5. Wyllie, A. H., Morris, R. G., Smith, A. L., and Dunlop, D. Chromatin cleavage in apoptosis:association with condensed chromatin morphology and dependence on macro-molecular synthesis. J. Pathol., 142:67–77, 1984.
6. Wyllie, A. H. Cell death. Int. Rev. Cytol., 17:755–785, 1987.
7. Kaufman, S. H. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etooside, camptotecin, and other cytotoxic anti-cancer drugs:a cautionary note. Cancer Res., 49:5870–5878, 1989.
8. Eastman, A. Activation of programmed cell death by anticancer agents:cisplatin as a model system. Cancer Cells (Cold Spring Harbor), 2:275–280, 1990.
9. Fritsche, M., Haessler, C., and Brandner, G. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene, 8:307–318, 1993.
10. Yin, D., Kondo, S., Takeuchi, J., and Morimura, T. Induction of apoptosis in murine ACTH-secreting pituitary adenoma cells by bromocriptine. FEBS Lett., 339:73–75, 1994.
11. Kondo, S., Yin, D., Morimura, T., and Takeuchi, J. Combination therapy with cisplatin and nifedipine induces apoptosis in multi-drug resistant human glioblastoma cells. J. Neurosurg., 82:469–474, 1995.
12. Kondo, S., Yin, D., Morimura, T., Kubo, H., Nakatsu, S., and Takeuchi, J. Combination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells. Br. J. Cancer, 71:282–289, 1995.
13. Levine, A. J., Momand, J., and Finlay, C. A. The p53 tumour suppressor gene. Nature (Lond.), 351; 453–456, 1991.
14. Shaulsky, G., Goldfinger, N., Peled, A., and Rotter, V. Involvement of wild-type p53 in pre-B-cell differentiation in vitro. Proc. Natl. Acad. Sci. USA, 88:8982–8986, 1991.
15. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A., and Oren, M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (Lond.), 352:345–347, 1991.
16. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., and Wyllie, A. H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.), 362:849–852, 1993.
17. Lowe, S. W., Earl-Ruley, H., Jacks, T., and Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74:957–967, 1993.
18. 1 arrest and apoptosis. Cancer Res., 54:1169–1174, 1994.
19. Strasser, A., Harris, A. W., Jacks, T., and Cory, S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bc1-2. Cell, 79:329–339, 1994.
20. Sen, S., and D'lncalci, M. Apoptosis. Biochemical events and relevance to cancer chemotherapy. FEBS Lett., 307:122–127, 1992.
21. Yuan, J., Shaham, S., Ledoux, S., Ellis, H. M., and Horvitz, H. R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-lβ-converting enzyme. Cell, 75:641–652, 1993.
22. Miura, M., Zhu, H., Rotello, R., Hartwieg, E. A., and Yuan, J. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell, 75:653–660, 1993.
23. Gagliardini, V., Fernandez, P-A., Lee, R. K. K., Drexler, H. C. A., Rotello, R. J., Fishman, M. C., and Yuan, J. Prevention of vertebrate neuronal death by the crmA gene. Science (Wash. DC), 263:826–828, 1994.
24. Vaux, D. L., Cory, S., and Adams, J. M. bcl-2 gene promotes haemopoietic cell survival and cooperates with c-mvc to immortalize pre-B cells. Nature (Lond.), 335:440–442, 1988.
25. Miyashita, T., and Reed, J. C. bcl-2 transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res., 52:5407–5411, 1992.
26. Boise, L. H., Gonzalez-Garcia, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nunez, G., and Thompson, C. B. bcl-X, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74:597–608, 1993.
27. Kondo, S., Yin, D., Aoki, T., Takahashi, J. A., Morimura, T., and Takeuchi, J. bcl-2 gene prevents apoptosis of basic fibroblast growth factor-deprived murine aortic endotheliac cells. Exp. Cell Res., 213:428–432, 1994.
28. Kondo, S., Yin, D., Morimura, T., Oda, Y., Kikuchi, H., and Takeuchi, J. bcl-2 gene enables rescue from in vitro myelosuppression (bone marrow cell death) induced by chemotherapy. Br. J. Cancer, 70:421–426, 1994.
29. Kondo, S., Yin, D., Morimura, T., Oda, Y., Kikuchi, H., and Takeuchi, J. Transfection with a bcl-2 expression vector protects transplanted bone marrow from chemotherapy-induced myelosuppression. Cancer Res., 54:2928–2933, 1994.
30. Akbasak, A., Oldfield, E. H., and Saris, S. C. Expression and modulation of major histocompatibility antigens on murine primary brain tumors in vitro. J. Neurosurg., 75:922–929, 1991.
31. Kondo, S., Barnett, G. H., Hara, H., Morimura, T., and Takeuchi, J. MDM2 protein confers the resistance of human glioblastoma cell line to cisplatin-induced apoptosis. Oncogene, 10:2001–2006, 1995.
32. Davis, L. G., Dibner, M. D., and Battery, J. F. Basic Methods in Molecular Biology. New York:Elsevier Science Publishing Co., Inc., 1986.
33. El-Deiry, W., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75:817–825, 1993.
34. Zambetti, G. P., Bargonetti, J., Walker, K., Prives, C., and Levine, A. J. Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes Dev., 6:1143–1152, 1992.
35. Black, R. A., Kronheim, S. R., Cantrell, M., Deeley, M. C., March, C. J., Prickett, K. S., Wignall, J., Conlon, P. J., Cosman, D., Hopp, T. P., and Mochizuki, D. Y. Generation of biologically active interleukin-1 β by proteolytic cleavage of the inactive precursor. J. Biol. Chem., 263:9437–9442, 1988.
36. Kostura, M. J., Tocci, M. J., Limjuco, G., Chin, J., Cameron, P., Hillman, A. G., Chartrain, N. A., and Schmidt, J. A. Identification of a monocyte specific pre-interleukin Iβ convertase activity. Proc. Natl. Acad. Sci. USA, 86:5227–5231, 1989.
37. Cerretti, D. P., Kozlosky, C. J., Mosley, B., Nelson, N., Van, N. K., Greenstreet, T. A., March, C. J., Kronheim, S. R., Druck, T., Cannizzaro, L. A., Huebner, K., and Black, R. A. Molecular cloning of the interleukin-1β converting enzyme. Science (Wash. DC), 256:97–100, 1992.
38. Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., Miller, D. K., Molineaux, S. M., Weidner, J. R., Aunins, J., Elliston, K. O., Ayala, J. M., Casano, F. J., Chin, J., Ding, G. J-F., Egger, L. A., Gaffney, E. P., Limjuco, G., Palyha, O. C., Raju, S. M., Rolando, A. M., Salley, J. P., Yamin, T.-T., Lee, T. D., Shively, J. E., MacCross, M., Mumford, R. A., Schmidt, J. A., and Tocci, M. J. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature (Lond.), 356:768–774, 1992.
39. Kumar, S., Kinoshita, M., Noda, M., Copeland, N. G., and Jenkins, N. A. Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabiditis elegans cell death gene ced-3 and the mammalian IL-1β-converting enzyme. Genes Dev., 8:1613–1626, 1994.
40. Wang, L., Miura, M., Bergeron, L., Zhu, H., and Yuan, J. Ich-1, an lce/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell, 78:739–750, 1994.
41. Walker, N. P. C., Talanian, R. V., Brady, K. D., Dang, L. C., Bump, N. J., Ferenz, C. R., Franklin, S., Ghayur, T., Hackett, M. C., Hammill, L. D., Herzog, L., Hugunin, M., Houy, W., Mankovich, J. A., McGuiness, L., Orlewicz, E., Paskind, M., Pratt, C. A., Reis, P., Summani, A., Terranova, M., Welch, J. P., Xiong, L., Moller, A., Tracey, D. E., Kamen, R., and Wong, W. W. Crystal structure of the cysteine proteases interleukin-1β-converting enzyme:a (p2Q/p10)2 homodimer. Cell, 78:343–352, 1994.
42. Wilson, K. P., Black, J. F., Thomson, J. A., Kim, E. E., Griffith, J. P., Navia, M. A., Murcko, M. A., Chambers, S. P., Aldape, R. A., Raybuck, S. A., and Livingston, D. J. Structure and mechanism of interleukin-1β-converting enzyme. Nature (Lond.), 370:270–275, 1994.
43. Li, P., Allen, H., Banerjee, S., Franklin, S., Herzog, L., Johnston, C., McDowell, J., Paskind, M., Rodman, L., Salfeld, J., Towne, E., Tracey, D., Wardwell, S., Wei, F-Y., Wong, W., Kamen, R., and Seshadri, T. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-Iβ and resistant to endotoxic shock. Cell, 80:401–411, 1995.
44. Korsmeyer, S. J. Bcl-2 initiates a new category of oncogenesis:regulators of cell death. Blood, 80:879–886, 1992.
45. Vaux, D. L., Weismann, I. L., and Kim, S. K. Prevention of programmed cell death in Caenorhabiditis elegans by human bcl-2. Science (Wash. DC), 258:1955–1957, 1992.